Enlicitide, an oral cholesterol-lowering drug, is catching attention among doctors as an option for patients who want an injection-free treatment. Merck has also achieved a key step in its cholesterol drug pipeline, while a cholesterol medicine developed with McMaster University research has been approved for use in Canada.

Health outlets this week reported on how exercise affects LDL cholesterol levels, and TODAY.com warned people about following cholesterol advice found on social media. LDL cholesterol is often called the 'bad' type because elevated levels are associated with heart disease.